Today: 22 June 2026
Browse Category

NSE:IDBI 5 February 2026

IDBI Bank shares rally again as privatisation bid deadline hits; analyst flags ₹130 target

IDBI Bank shares rally again as privatisation bid deadline hits; analyst flags ₹130 target

IDBI Bank shares rose 2% to 111.57 rupees Thursday, outperforming a falling Nifty 50, as investors eyed the government's 60.7% stake sale. The deadline for financial bids is set for Feb. 5, with Fairfax, Emirates NBD, and Kotak Mahindra Bank cleared to bid. Trading volumes spiked Wednesday, with 41.5 million shares exchanged. Employee unions have urged the government to reconsider selling to private or foreign buyers.
5 February 2026

Stock Market Today

  • Stephen King praises 2026 horror hit 'Obsession' as breakout success
    June 22, 2026, 3:03 AM EDT. Stephen King endorsed 'Obsession,' a breakout 2026 horror film directed by YouTuber Curry Barker, describing it as a 'weird mixture of humor and horror.' The feature, made on a micro-budget of under $1 million, has grossed over $297 million worldwide and holds a 94% critic score on Rotten Tomatoes, highlighting its massive box office and critical success. This debut film has gained major acclaim, including from The Independent, which called it 'one of the creepiest horror movies of 2026.' The rise of YouTube filmmakers like Barker signals a new trend in horror, alongside similar hits such as Cane Parson's 'Backrooms.'

Latest articles

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

22 June 2026
Cognizant shares plunged 10.49% to $43.70, erasing $2.4 billion in equity value—more than its $2 billion 2026 buyback target—after Accenture’s narrowed growth outlook, a Berenberg downgrade, and looming Nasdaq-100 removal, even as S&P 500 and Nasdaq rallied; investors now eye Q2 guidance as the next key test.
Pentagon Could Outpace Tech Giants on Small Nuclear Projects

Pentagon Could Outpace Tech Giants on Small Nuclear Projects

22 June 2026
Valar Atomics’ Ward 250 became the first DOE-authorized advanced reactor built outside a national lab to achieve criticality, signaling a shift as U.S. defense demand accelerates small nuclear deployment, with the Army allocating over $2 billion for microreactors—moving the sector from policy to production and raising near-term demand expectations.
Go toTop